A. Mathieu-Boué

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Nöel Milpied, B. Vasseur, Nathalie Parquet et al. · Annals of Oncology · 2000 · 376 citations · Full text

Lymphoid Neoplasia, Transplantation, Immunosuppressive Therapy +10

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study

D.J.Th. Wagener, H.E.R. Verdonk, Luc Dirix et al. · Annals of Oncology · 1995 · 182 citations

Pancreatic Cancer, Phase Ii Trial, Gastrointestinal Oncology +9

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.

Peter J. Houghton, Pamela J. Cheshire, James C. Hallman et al. · PubMed · 1993 · 161 citations

Tumor Biology, Human Tumor Xenografts, Medicine +14

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.

M Forni, R. Bugat, G G Chabot et al. · PubMed · 1994 · 151 citations

Pharmacokinetic Study, Pathology, Pharmacotherapy +17

Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients

Delphine Kérob, Raphaël Porcher, O Vérola et al. · Clinical Cancer Research · 2010 · 149 citations · Full text